Carmine Stengone is President and Chief Executive Officer of Contineum Therapeutics, Inc. (CTNM). The company reported total compensation of $3,409,448 for fiscal year 2025.
| Salary | $655,620 |
|---|---|
| Bonus | $0 |
| Stock awards | $0 |
| Option awards | $2,291,640 |
| Non-equity incentive plan | $450,739 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $11,449 |
| Total | $3,409,448 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Contineum Therapeutics, Inc. filed April 30, 2026, accession 0001628280-26-028881.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | President and Chief Executive Officer | $655,620 | $0 | $0 | $2,291,640 | $450,739 | $0 | $11,449 | $3,409,448 |
| FY2024 | President and Chief Executive Officer | $608,120 | $55,000 | $0 | $3,806,147 | $418,146 | $0 | $12,627 | $4,900,039 |
Totals as disclosed in each year's own compensation disclosure for Contineum Therapeutics, Inc..
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Carmine Stengone this page | President and Chief Executive Officer | $3,409,448 |
| Timothy Watkins | Chief Medical Officer and Head of Development | $1,763,323 |
| Peter Slover | Chief Financial Officer | $1,577,903 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Contineum Therapeutics, Inc. compensation brief.
Carmine Stengone's compensation sits inside Contineum Therapeutics, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.